Back to top

cannabis: Archive

Zacks Equity Research

SHFS Stock Declines Post Q3 Earnings Despite Loan and Deposit Growth

SHF Holdings' third-quarter 2026 results reflect higher loan income and deposit growth, as rising losses, cash pressures and litigation risks cloud its outlook.

SHFSPositive Net Change

Zacks Equity Research

JAZZ Q3 Earnings & Sales Beat Estimates, Raises '26 Sales View

Jazz Pharmaceuticals beat Q3 2026 revenue and earnings estimates, driven by oncology and rare sleep growth, and raises its full-year sales outlook.

JAZZNegative Net Change TGTXNegative Net Change AMRXNegative Net Change

Ethan Feller

Bull of the Day: Aurora Cannabis (ACB)

Aurora Cannabis stock has moved sharply higher from its recent lows following broad industry developments and fundamental improvements to the core business.

ACBNegative Net Change

Debanjana Dey

Zacks Initiates Coverage of Safe Harbor With Neutral Recommendation

Discover why Zacks rates Safe Harbor as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore SHFS' improving lending economics and expanding financial services offerings amid ongoing losses and regulatory uncertainty.

SHFSPositive Net Change

Zacks Equity Research

Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs

ACB frames fiscal 2027 as a reset year as Canadian reimbursement pressure weighs on margins, even as global medical cannabis growth continues.

ACBNegative Net Change

Moumita C. Chattopadhyay

Is IIPR a High-Yield Value Play at 6.8x Forward Earnings?

IIPR offers a 14.9% yield and trades at 6.83x forward earnings as rent recovery efforts and 2026 maturities shape the debate.

SMANegative Net Change LTCNegative Net Change IIPRNegative Net Change

Moumita C. Chattopadhyay

IIPR and Cannabis Reform: 280E Relief and Schedule III Upside

IIPR nears an inflection point: Schedule III and 280E relief could boost tenant cash flow, supporting rent stability, re-leasing and growth.

LTCNegative Net Change GTYPositive Net Change IIPRNegative Net Change

Zacks Equity Research

Implied Volatility Surging for Aurora Cannabis Stock Options

Investors need to pay close attention to ACB stock based on the movements in the options market lately.

ACBNegative Net Change

Zacks Equity Research

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

Jazz Pharmaceuticals beats Q4 earnings and revenue estimates as neuroscience and oncology sales climb, sending shares up 5% in after hours.

JAZZNegative Net Change CSTLNegative Net Change IMCRNegative Net Change

Zacks Equity Research

Can Cannabis Strength in Canada Drive Canopy's Q3 Earnings?

CGC heads into Q3 with Canada cannabis momentum, new product launches and a $50.6M revenue view ahead of Feb. 6 results.

CAHPositive Net Change MMSINegative Net Change VCYTPositive Net Change CGCNegative Net Change